Regeneron Pharmaceuticals REGN SEC Filings

NASDAQ REGN
$831.89 -11.58 (-1.37%)
As of: Sep 4, 2026 · 2:25 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Regeneron Pharmaceuticals, Inc. (REGN) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index